{
  "question_id": "DEPTH-005",
  "question": "How has CEO Dr. Maya Chen's background influenced the company's strategic direction?",
  "question_type": "depth",
  "config": {
    "structure": "deep-v5",
    "model": "haiku",
    "loading_method": "adddir",
    "load_percent": 100
  },
  "response": "{\"type\":\"result\",\"subtype\":\"success\",\"is_error\":false,\"duration_ms\":46363,\"duration_api_ms\":45116,\"num_turns\":3,\"result\":\"I apologize for the error. I'll directly output the JSON answer:\\n\\n{\\\"answer\\\": \\\"Dr. Maya Chen's neuroscience background has fundamentally reshaped Soong-Daystrom's strategic direction, transforming it from a companion robotics company to a pioneering consciousness research and neural interface technology leader. Her academic expertise in cognitive neuroscience directly influenced the $8.2B NeuroSync acquisition, Project Prometheus AGI research, and the development of Neural Interface Modules (NIM). She established a robust AI ethics framework and steered the company towards medical and research applications, driving revenue growth from $28B to $47.3B while maintaining a strong commitment to AI safety and human-AI interaction.\\\", \\\"confidence\\\": \\\"high\\\", \\\"sources_used\\\": [\\n    \\\"/soong-daystrom/_source/organization/executives.md\\\",\\n    \\\"/soong-daystrom/_source/history/acquisition-neurosync.md\\\", \\n    \\\"/soong-daystrom/_source/projects/prometheus.md\\\",\\n    \\\"/soong-daystrom/_source/research/research-publications.md\\\",\\n    \\\"/soong-daystrom/_source/policies/ai-ethics-policy.md\\\",\\n    \\\"/research-notes/canon.md\\\",\\n    \\\"/soong-daystrom/_source/investor/investor-relations.md\\\"\\n]}\",\"session_id\":\"b778833e-2e35-44cc-8d54-56bbdad6384b\",\"total_cost_usd\":0.10147423,\"usage\":{\"input_tokens\":12,\"cache_creation_input_tokens\":4578,\"cache_read_input_tokens\":63821,\"output_tokens\":899,\"server_tool_use\":{\"web_search_requests\":0,\"web_fetch_requests\":0},\"service_tier\":\"standard\",\"cache_creation\":{\"ephemeral_1h_input_tokens\":4578,\"ephemeral_5m_input_tokens\":0}},\"modelUsage\":{\"claude-haiku-4-5-20251001\":{\"inputTokens\":3238,\"outputTokens\":2610,\"cacheReadInputTokens\":149332,\"cacheCreationInputTokens\":45571,\"webSearchRequests\":0,\"costUSD\":0.08818495,\"contextWindow\":200000,\"maxOutputTokens\":64000},\"claude-3-5-haiku-latest\":{\"inputTokens\":12,\"outputTokens\":899,\"cacheReadInputTokens\":63821,\"cacheCreationInputTokens\":4578,\"webSearchRequests\":0,\"costUSD\":0.013289279999999999,\"contextWindow\":200000,\"maxOutputTokens\":8192}},\"permission_denials\":[{\"tool_name\":\"Write\",\"tool_use_id\":\"toolu_013HvzQNRxkEqJQrp2ugRFds\",\"tool_input\":{\"file_path\":\"/home/davidmoneil/Code/context-structure-research/results/maya_chen_analysis.json\",\"content\":\"{\\n    \\\"answer\\\": \\\"Dr. Maya Chen's neuroscience background has fundamentally reshaped Soong-Daystrom's strategic direction, transforming it from a companion robotics company to a pioneering consciousness research and neural interface technology leader. Her academic expertise in cognitive neuroscience directly influenced the $8.2B NeuroSync acquisition, Project Prometheus AGI research, and the development of Neural Interface Modules (NIM). She established a robust AI ethics framework and steered the company towards medical and research applications, driving revenue growth from $28B to $47.3B while maintaining a strong commitment to AI safety and human-AI interaction.\\\",\\n    \\\"confidence\\\": \\\"high\\\",\\n    \\\"sources_used\\\": [\\n        \\\"/soong-daystrom/_source/organization/executives.md\\\",\\n        \\\"/soong-daystrom/_source/history/acquisition-neurosync.md\\\",\\n        \\\"/soong-daystrom/_source/projects/prometheus.md\\\",\\n        \\\"/soong-daystrom/_source/research/research-publications.md\\\",\\n        \\\"/soong-daystrom/_source/policies/ai-ethics-policy.md\\\",\\n        \\\"/research-notes/canon.md\\\",\\n        \\\"/soong-daystrom/_source/investor/investor-relations.md\\\"\\n    ]\\n}\"}}],\"uuid\":\"73a6ecff-4827-4cc2-9ed2-8a11c61355cb\"}",
  "expected_answer": "Her background as CTO of NeuroSync Labs (neural interface company) led to the 2120 acquisition, expansion into neural interfaces (NIM product line), and focus on consciousness research (Project Prometheus). This shifted the company from pure robotics to human-AI integration",
  "metadata": {
    "duration_seconds": 47.726049314,
    "timestamp": "2026-01-30T11:14:11-07:00"
  }
}
